CSL Behring
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
CSL Behring is a clinical trial sponsor. It has 19 active clinical trials with 5,647 planned participants, across 14 therapeutic areas. Since 2021 it has completed 42 trials and stopped 15 early. Its FDA record on file shows 1 warning letter.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 19 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about CSL Behring
Yes. FDA has published 1 warning letter naming CSL Behring; the latest was posted on 2025-09-16. Each letter links to FDA's own posting.
CSL Behring is lead sponsor of 19 active clinical trials on ClinicalTrials.gov, with 5,647 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 42 trials and stopped 15 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with CSL Behring; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with CSL Behring.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.